Representativeness of Patients With Lung Cancer in an Integrated Health Care Delivery System.

Lung cancer integrated health care systems observational research

Journal

The Permanente journal
ISSN: 1552-5775
Titre abrégé: Perm J
Pays: United States
ID NLM: 9800474

Informations de publication

Date de publication:
12 Jun 2024
Historique:
medline: 9 7 2024
pubmed: 9 7 2024
entrez: 9 7 2024
Statut: aheadofprint

Résumé

Observational research is important for understanding the real-world benefits of advancements in lung cancer care. Integrated health care systems, such as Kaiser Permanente Northern California, have extensive electronic health records suitable for such research, but the generalizability of their populations is often questioned. Leveraging data from the California Cancer Registry, the authors compared distributions of demographic and clinical characteristics, in addition to neighborhood and environmental conditions, between patients diagnosed with lung cancer from 2015 through 2019 at Kaiser Permanente Northern California, National Cancer Institute-designated cancer centers (NCICCs), and all other non-NCICC hospitals within the same catchment area. Of 20,178 included patients, 30% were from Kaiser Permanente Northern California, 8% from NCICCs, and 62% from other non-NCICC hospitals. Compared to NCICC patients, Kaiser Permanente Northern California patients were more similar to other non-NCICC patients on most characteristics. Compared to other non-NCICC patients, Kaiser Permanente Northern California patients were slightly older, more likely to be female, and less likely to be Hispanic or Asian/Pacific Islander and to reside in lower socioeconomic status (SES) neighborhoods. In contrast, NCICC patients were younger, less likely to be female or from non-Asian/Pacific Islander minoritized racial groups, and more likely to present with early-stage disease and adenocarcinoma and to reside in neighborhoods with higher SES and lower air pollution than Kaiser Permanente Northern California or other non-NCICC patients. Patients from Kaiser Permanente Northern California, compared to NCICCs, are more broadly representative of the underlying patient population with lung cancer. Research using electronic health record data from integrated health care systems can contribute generalizable real-world evidence to benchmark and improve lung cancer care.

Identifiants

pubmed: 38980792
doi: 10.7812/TPP/24.028
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-10

Auteurs

Mike Z Yang (MZ)

Internal Medicine Residency, Kaiser Permanente Northern California, San Francisco, CA, USA.

Raymond Liu (R)

Department of Medical Oncology, Kaiser Permanente Northern California, San Francisco, CA, USA.
Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.

Julie Von Behren (J)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.

Katherine Lin (K)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.

Alyce S Adams (AS)

Department of Health Policy, Stanford University School of Medicine, Stanford, CA, USA.

Lawrence H Kushi (LH)

Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.

Charles P Quesenberry (CP)

Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.

Jeffrey B Velotta (JB)

Department of Thoracic Surgery, Kaiser Permanente Northern California, Oakland, CA, USA.

Melisa L Wong (ML)

Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Division of Geriatrics, University of California, San Francisco, San Francisco, CA, USA.

Kelly C Young-Wolff (KC)

Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.

Scarlett L Gomez (SL)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.

Salma Shariff-Marco (S)

Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.

Lori C Sakoda (LC)

Division of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.

Classifications MeSH